Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 10, 2025 • 4:31 PM ET

Date/Time Source News Release
05/12/2025 06:00 PM EDT Newsfile InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update
02/12/2025 06:54 PM EST Newsfile InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
02/03/2025 07:30 AM EST Newsfile InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
01/22/2025 07:30 AM EST Newsfile InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
01/21/2025 07:30 AM EST Newsfile InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
12/18/2024 08:00 PM EST Newsfile InMed Announces Results of 2024 Annual General Meeting
12/17/2024 04:56 PM EST Newsfile InMed Enters Into Standby Equity Purchase Agreement
11/19/2024 07:30 AM EST Newsfile InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System
11/14/2024 04:45 PM EST Newsfile InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
11/08/2024 04:44 PM EST Newsfile InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules
Page

Additional News

As of June 10, 2025 • 4:31 PM ET

Date/Time Source News Release
06/02/2025 10:29 AM EDT IBN Spotlights InMed Pharmaceuticals Inc. (NASDAQ: INM) Sees Notable Increase in Monday Morning Market Activity
06/02/2025 09:04 AM EDT 24/7 Market News Siyata Mobile's $160M Core Gaming Merger Closing Date Nears Without Advance Notice
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - InMed Pharmaceuticals Inc.
05/12/2025 06:02 PM EDT SeekingAlpha InMed Pharmaceuticals Non-GAAP EPS of -$1.94, revenue of $1.26M
02/13/2025 02:33 AM EST SeekingAlpha InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M
02/11/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, February 11th, 2025
02/11/2025 04:30 AM EST US Earnings Reports Expected earnings - InMed Pharmaceuticals Inc.
01/21/2025 10:31 AM EST 24/7 Market News Six Hot Post Inauguration Trades: HSDT, INM, RGTI, EONR, QBTS, QUBT
01/21/2025 09:54 AM EST Baystreet InMed Hails Alzheimer's Study, Stocks Shoot Higher
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.